Serum pentraxin 3 concentration in patients with type 2 diabetes and nonalcoholic fatty liver disease.

MLA

Trojak, Aleksandra, et al. “Serum Pentraxin 3 Concentration in Patients with Type 2 Diabetes and Nonalcoholic Fatty Liver Disease.” Polish Archives of Internal Medicine, vol. 129, no. 7/8, July 2019, pp. 499–505. EBSCOhost, https://doi.org/10.20452/pamw.14913.

APA

Trojak, A., Waluś-Miarka, M., Kapusta, M., Miarka, P., Kawalec, E., Idzior-Waluś, B., & Małecki, M. T. (2019). Serum pentraxin 3 concentration in patients with type 2 diabetes and nonalcoholic fatty liver disease. Polish Archives of Internal Medicine, 129(7/8), 499–505. https://doi.org/10.20452/pamw.14913

Chicago

Trojak, Aleksandra, Małgorzata Waluś-Miarka, Maria Kapusta, Przemysław Miarka, Ewa Kawalec, Barbara Idzior-Waluś, and Maciej T. Małecki. 2019. “Serum Pentraxin 3 Concentration in Patients with Type 2 Diabetes and Nonalcoholic Fatty Liver Disease.” Polish Archives of Internal Medicine 129 (7/8): 499–505. doi:10.20452/pamw.14913.